SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director acquired a small number of shares through the routine vesting of Restricted Stock Units (RSUs), a standard part of their compensation plan.
• Market Impact: This transaction is considered neutral and is not expected to have any impact on the stock price or trading volume.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	Medical Laboratories

Insider Information

Field	Value
Name	Hidalgo Medina Manuel
CIK	0001865525
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-17
Transaction Code	M (Exercise/Vesting)
Security Type	Common Stock
Shares Involved	232
Price Per Share	$0.00
Total Value	$0
Shares Owned After	1,029
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	232
% of Shares Outstanding	Not Available
Post-Transaction Ownership	1,029 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0. The acquisition of 232 shares is negligible for a company with a market capitalization of $12.26 billion.
• Ownership Concentration: The director's total holding of 1,029 shares represents an insignificant portion of the company's total equity.
• Dilution Impact: This specific vesting event has a minimal dilutive effect as the shares were part of a previously disclosed grant from July 2024.
• Transaction Significance: The transaction is a routine, non-discretionary event (vesting of RSUs) and holds no significance as an indicator of insider sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a pre-scheduled vesting of equity compensation, not an open-market transaction. It does not reflect a new investment decision by the insider.

Volume & Sentiment

• Expected Volume Impact: None. The transaction did not occur on the open market.
• Sentiment Indicator: Neutral. The filing is informational and relates to a standard compensation event.

Additional Context

Transaction Notes

• Special Circumstances: The transaction represents the vesting of Restricted Stock Units that were granted on July 17, 2024, as part of a four-year vesting schedule. This is a routine part of the director's compensation package.